An experimental drug currently being trialled for influenza and Ebola viruses could have a new target: norovirus, often known as the winter vomiting virus. A team of researchers has shown that the drug, favipiravir, is effective at reducing — and in some cases eliminating — norovirus infection in mice
KSWFoodWorld
FoodWorld 